Glucocorticoids Impair the 7α-Hydroxycholesterol-Enhanced Innate Immune Response
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Glucocorticoids suppress the vascular inflammation that occurs under hypercholesterolemia, as demonstrated in an animal model fed a high-cholesterol diet. However, the molecular mechanisms underlying these beneficial effects remain poorly understood. Because cholesterol is oxidized to form cholesterol oxides (oxysterols) that are capable of inducing inflammation, we investigated whether glucocorticoids affect the immune responses evoked by 7α-hydroxycholesterol (7αOHChol). The treatment of human THP-1 monocytic cells with dexamethasone (Dex) and prednisolone (Pdn) downregulated the expression of pattern recognition receptors (PRRs), such as TLR6 and CD14, and diminished 7αOHChol-enhanced response to FSL-1, a TLR2/6 ligand, and lipopolysaccharide, which interacts with CD14 to initiate immune responses, as determined by the reduced secretion of IL-23 and CCL2, respectively. Glucocorticoids weakened the 7αOHChol-induced production of CCL2 and CCR5 ligands, which was accompanied by decreased migration of monocytic cells and CCR5-expressing Jurkat T cells. Treatment with Dex or Pdn also reduced the phosphorylation of the Akt-1 Src, ERK1/2, and p65 subunits. These results indicate that both Dex and Pdn impair the expression of PRRs and their downstream products, chemokine production, and phosphorylation of signaling molecules. Collectively, glucocorticoids suppress the innate immune response and activation of monocytic cells to an inflammatory phenotype enhanced or induced by 7αOHChol, which may contribute to the anti-inflammatory effects in hypercholesterolemic conditions.
Abstract
Glucocorticoids suppress the vascular inflammation that occurs under hypercholesterolemia, as demonstrated in an animal model fed a high-cholesterol diet. However, the molecular mechanisms underlying these beneficial effects remain poorly understood. Because cholesterol is oxidized to form cholesterol oxides (oxysterols) that are capable of inducing inflammation, we investigated whether glucocorticoids affect the immune responses evoked by 7α-hydroxycholesterol (7αOHChol). The treatment of human THP-1 monocytic cells with dexamethasone (Dex) and prednisolone (Pdn) downregulated the expression of pattern recognition receptors (PRRs), such as TLR6 and CD14, and diminished 7αOHChol-enhanced response to FSL-1, a TLR2/6 ligand, and lipopolysaccharide, which interacts with CD14 to initiate immune responses, as determined by the reduced secretion of IL-23 and CCL2, respectively. Glucocorticoids weakened the 7αOHChol-induced production of CCL2 and CCR5 ligands, which was accompanied by decreased migration of monocytic cells and CCR5-expressing Jurkat T cells. Treatment with Dex or Pdn also reduced the phosphorylation of the Akt-1 Src, ERK1/2, and p65 subunits. These results indicate that both Dex and Pdn impair the expression of PRRs and their downstream products, chemokine production, and phosphorylation of signaling molecules. Collectively, glucocorticoids suppress the innate immune response and activation of monocytic cells to an inflammatory phenotype enhanced or induced by 7αOHChol, which may contribute to the anti-inflammatory effects in hypercholesterolemic conditions.
참고문헌 (53)
- Timmermans S, "A general introduction to glucocorticoid biology", Front Immunol, 10, pp.1545~ (2019)
- Bailey JM, "Anti-inflammatory drugs in experimental atherosclerosis. I. Relative potencies for inhibiting plaque formation", Atherosclerosis, 17, pp.515~522 (1973)
- Asai K, "Dexamethasone-induced suppression of aortic atherosclerosis in cholesterol-fed rabbits. Possible mechanisms", Arterioscler Thromb, 13, pp.892~899 (1993)
- Poon M, "Dexamethasone inhibits macrophage accumulation after balloon arterial injury in cholesterol fed rabbits", Atherosclerosis, 155, pp.371~380 (2001)
- Joner M, "Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma", Arterioscler Thromb Vasc Biol, 28, pp.1960~1966 (2008)
- Rhen T, "Antiinflammatory action of glucocorticoids--new mechanisms for old drugs", N Engl J Med, 353, pp.1711~1723 (2005)
- Hardy RS, "Therapeutic glucocorticoids : mechanisms of actions in rheumatic diseases", Nat Rev Rheumatol, 16, pp.133~144 (2020)
- Brown AJ, "Oxysterols and atherosclerosis", Atherosclerosis, 142, pp.1~28 (1999)
- Carpenter KL, "Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development", Biochim Biophys Acta, 1256, pp.141~150 (1995)
- Brown AJ, "7-Hydroperoxycholesterol and its products in oxidized low density lipoprotein and human atherosclerotic plaque", J Lipid Res, 38, pp.1730~1745 (1997)
- 서현철, "7a-Hydroxycholesterol Elicits TLR6-Mediated Expression of IL-23 in Monocytic Cells", Biomolecules & Therapeutics, 23(1), pp.84~89 (2015), 한국응용약물학회
- Kim SM, "27-Hydroxycholesterol and 7alpha-hydroxycholesterol trigger a sequence of events leading to migration of CCR5-expressing Th1 lymphocytes", Toxicol Appl Pharmacol, 274, pp.462~470 (2014)
- Kim SM, "7α-Hydroxycholesterol induces inflammation by enhancing production of chemokine(C-C motif)ligand 2", Biochem Biophys Res Commun, 467, pp.879~884 (2015)
- Fujiwara N, "Macrophages in inflammation", Curr Drug Targets Inflamm Allergy, 4, pp.281~286 (2005)
- Kharraz Y, "Macrophage plasticity and the role of inflammation in skeletal muscle repair", Mediators Inflamm, 2013, pp.491497~ (2013)
- Zhang C, "Function of macrophages in disease : current understanding on molecular mechanisms", Front Immunol, 12, pp.620510~ (2021)
- Park D, "The adaptor protein Lad associates with the G protein beta subunit and mediates chemokine-dependent T-cell migration", Blood, 109, pp.5122~5128 (2007)
- 최정윤, "Reblastatins Inhibit Phenotypic Changes of Monocytes", Macrophages in a Milieu Rich in 27-Hydroxycholesterol, 2020, pp.20(2), 1~18[DOI]
- Livak KJ, "Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt Method", Methods, 25, pp.402~408 (2001)
- Son H, "Shear stress induces monocyte", macrophage-mediated inflammation by upregulating cell-surface expression of heat shock proteins, 2023, pp.161, 114566~
- Schroder K, "The inflammasomes", Cell, 140, pp.821~832 (2010)
- 노종성, "Damage-Associated Molecular Patterns in Inflammatory Diseases", Immune Network, 18(4), pp.1~14 (2018), 대한면역학회[DOI]
- Tang D, "PAMPs and DAMPs : signal 0s that spur autophagy and immunity", Immunol Rev, 249, pp.158~175 (2012)
- Takeda K, "Toll-like receptors", Annu Rev Immunol, 21, pp.335~376 (2003)
- Takeuchi O, "TLR6 : a novel member of an expanding toll-like receptor family", Gene, 231, pp.59~65 (1999)
- Kitchens RL, "Role of CD14 in cellular recognition of bacterial lipopolysaccharides", Chem Immunol, 74, pp.61~82 (2000)
- Chun KH, "CD14 but not MD2 transmit signals from DAMP", Int Immunopharmacol, 10, pp.98~106 (2010)
- Ranoa DR, "Human lipopolysaccharide-binding protein(LBP)and CD14 independently deliver triacylated lipoproteins to Toll-like receptor 1(TLR1)and TLR2 and enhance formation of the ternary signaling complex", J Biol Chem, 288, pp.9729~9741 (2013)
- Lévêque M, "Soluble CD14 acts as a DAMP in human macrophages : origin and involvement in inflammatory cytokine", chemokine production, 2017, pp.31, 1891~1902
- Takeuchi O, "Pattern recognition receptors and inflammation", Cell, 140, pp.805~820 (2010)
- McKernan DP, "Pattern recognition receptors as potential drug targets in inflammatory disorders", Adv Protein Chem Struct Biol, 119, pp.65~109 (2020)
- Loetscher P, "CCR5 is characteristic of Th1 lymphocytes", Nature, 391, pp.344~345 (1998)
- Roberts CA, "The interplay between monocytes", macrophages and CD4+ T cell subsets in rheumatoid arthritis, 2015, pp.6, 571~
- Davignon JL, "Targeting monocytes", macrophages in the treatment of rheumatoid arthritis, 2013, pp.52, 590~598
- Gordon S, "Monocyte and macrophage heterogeneity", Nat Rev Immunol, 5, pp.953~964 (2005)
- Ruterbusch M, "In vivo CD4+ T cell differentiation and function : revisiting the Th1", Th2 paradigm, 2020, pp.38, 705~725
- Baidya SG, "Helper T cells and atherosclerosis : the cytokine web", Postgrad Med J, 81, pp.746~752 (2005)
- Frostegård J, "Cytokine expression in advanced human atherosclerotic plaques : dominance of pro-inflammatory(Th1)and macrophage-stimulating cytokines", Atherosclerosis, 145, pp.33~43 (1999)
- Dardalhon V, "Role of Th1 and Th17 cells in organ-specific autoimmunity", J Autoimmun, 31, pp.252~256 (2008)
- Shiojima I, "Role of Akt signaling in vascular homeostasis and angiogenesis", Circ Res, 90, pp.1243~1250 (2002)
- Lavoie H, "ERK signalling : a master regulator of cell behaviour, life and fate", Nat Rev Mol Cell Biol, 21, pp.607~632 (2020)
- Cho HR, "7α-Hydroxycholesterol induces monocyte", macrophage cell expression of interleukin-8 via C5a receptor, 2017, pp.12, e0173749~
- 손용해, "PI3K and ERK signaling pathways are involved in differentiation of monocytic cells induced by 27-hydroxycholesterol", The Korean Journal of Physiology & Pharmacology, 21(3), pp.301~308 (2017), 대한약리학회
- Kassel O, "Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1", EMBO J, 20, pp.7108~7116 (2001)
- Wang X, "Inhibition of PI3-kinase signaling by glucocorticoids results in increased branched-chain amino acid degradation in renal epithelial cells", Am J Physiol Cell Physiol, 292, pp.C1874~C1879 (2007)
- Cho HR, "27-Hydroxycholesterol induces expression of zonula occludens-1 in monocytic cells via multiple kinases pathways", Sci Rep, 12, pp.8213~ (2022)
- Kim BY, "Prednisolone suppresses the immunostimulatory effects of 27-hydroxycholesterol", Exp Ther Med, 19, pp.2335~2342 (2020)
- Kim BY, "Dexamethasone inhibits activation of monocytes", macrophages in a milieu rich in 27-oxygenated cholesterol, 2017, pp.12, e0189643~
- Ronchetti S, "Defining the role of glucocorticoids in inflammation", Clin Sci(Lond), 132, pp.1529~1543 (2018)
- Hanaoka BY, "Glucocorticoid effects on skeletal muscle : benefit and risk in patients with autoimmune inflammatory rheumatoid diseases", Expert Rev Clin Immunol, 8, pp.695~697 (2012)
- Costello RE, "Glucocorticoid use is associated with an increased risk of hypertension", Rheumatology(Oxford), 60, pp.132~139 (2021)
- Verhoeven F, "Glucocorticoids and endothelial function in inflammatory diseases : focus on rheumatoid arthritis", Arthritis Res Ther, 18, pp.258~ (2016)
- Meng X, "The hyperlipidemia caused by overuse of glucocorticoid after liver transplantation and the immune adjustment strategy", J Immunol Res, 2017, pp.3149426~ (2017)